| Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer C Biot, CA Rentsch, JR Gsponer, FD Birkhäuser, H Jusforgues-Saklani, ... Science translational medicine 4 (137), 137ra72-137ra72, 2012 | 273 | 2012 |
| Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy CA Rentsch, FD Birkhäuser, C Biot, JR Gsponer, A Bisiaux, C Wetterauer, ... European urology 66 (4), 677-688, 2014 | 210 | 2014 |
| Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis D Juskevicius, T Lorber, J Gsponer, V Perrina, C Ruiz, F Stenner-Liewen, ... Leukemia 30 (12), 2385-2395, 2016 | 101 | 2016 |
| Characterization and clinical relevance of ALDHbright populations in prostate cancer C Le Magnen, L Bubendorf, CA Rentsch, C Mengus, J Gsponer, ... Clinical cancer research 19 (19), 5361-5371, 2013 | 83 | 2013 |
| Early development of human lymphomas in a prostate cancer xenograft program using triple knock‐out immunocompromised mice C Wetterauer, T Vlajnic, J Schüler, JR Gsponer, GN Thalmann, ... The Prostate 75 (6), 585-592, 2015 | 68 | 2015 |
| Deep clonal profiling of formalin fixed paraffin embedded clinical samples T Holley, E Lenkiewicz, L Evers, W Tembe, C Ruiz, JR Gsponer, ... PloS one 7 (11), e50586, 2012 | 57 | 2012 |
| Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration … T Zellweger, S Stürm, S Rey, I Zlobec, JR Gsponer, CA Rentsch, ... Endocrine-related cancer 20 (3), 403-413, 2013 | 50 | 2013 |
| Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure—experience with 400 patients C Wetterauer, O Shahin, JR Federer-Gsponer, N Keller, S Wyler, ... Prostate cancer and prostatic diseases 23 (3), 429-434, 2020 | 48 | 2020 |
| Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma–reasons and consequences L Arabi, JR Gsponer, J Smida, M Nathrath, V Perrina, G Jundt, C Ruiz, ... Genes & cancer 5 (1-2), 56, 2014 | 41 | 2014 |
| Structured reporting of prostate magnetic resonance imaging has the potential to improve interdisciplinary communication C Wetterauer, DJ Winkel, JR Federer-Gsponer, A Halla, S Subotic, ... PLoS One 14 (2), e0212444, 2019 | 34 | 2019 |
| Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance JR Federer‐Gsponer, C Quintavalle, DC Mueller, T Dietsche, V Perrina, ... The Journal of pathology 245 (1), 74-84, 2018 | 26 | 2018 |
| VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities M Andreozzi, L Quagliata, JR Gsponer, C Ruiz, V Vuaroqueaux, ... Angiogenesis 17, 519-527, 2014 | 26 | 2014 |
| ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer JR Gsponer, M Braun, VJ Scheble, T Zellweger, A Bachmann, S Perner, ... Prostate cancer and prostatic diseases 17 (2), 126-131, 2014 | 24 | 2014 |
| Patterns of stemness‐associated markers in the development of castration‐resistant prostate cancer JR Federer‐Gsponer, DC Mueller, T Zellweger, M Eggimann, K Marston, ... The Prostate 80 (13), 1108-1117, 2020 | 20 | 2020 |
| Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer SG Dugas, DC Müller, C Le Magnen, J Federer‐Gsponer, HH Seifert, ... Cancer cytopathology 127 (9), 578-585, 2019 | 17 | 2019 |
| Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up C Wetterauer, M Weibel, JR Gsponer, T Vlajnic, T Zellweger, S Bütikofer, ... Virchows Archiv 465, 629-636, 2014 | 16 | 2014 |
| BCG-mediated bladder cancer immunotherapy: identifying determinants of treatment response using a calibrated mathematical model CA Rentsch, C Biot, JR Gsponer, A Bachmann, ML Albert, R Breban PloS one 8 (2), e56327, 2013 | 16 | 2013 |
| Building on a solid foundation: enhancing bacillus Calmette-Guerin therapy CA Rentsch, L Derré, SG Dugas, C Wetterauer, JR Federer-Gsponer, ... European urology focus 4 (4), 485-493, 2018 | 12 | 2018 |
| Novices in MRI-targeted prostate biopsy benefit from structured reporting of MRI findings C Wetterauer, DJ Winkel, JR Federer-Gsponer, F Leboutte, T Horn, ... World journal of urology 38, 1729-1734, 2020 | 7 | 2020 |
| Immunotherapy of bladder cancer using bacillus calmette guerin (BCG): Generation of cytotoxic T-cells is BCG strain dependent JR Gsponer, C Biot, A Bisiaux, GN Thalmann, A Bachmann, L Bubendorf, ... Cancer Research 72 (8_Supplement), 5386-5386, 2012 | 6 | 2012 |
Lukas BubendorfProfessor, Institute of Pathology, University Hospital BaselVerified email at usb.ch
